Can B Corp (NASC) stock
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Can B's EPS for the twelve months ending Sep 30, 2023 was -$1.79. For fiscal 2023 it was -$0.77. The highest annual figure on record is $0.00 in fiscal 2016.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$0.77 | – |
| FY2022 | Dec 31, 2022 | -$4.18 | – |
| FY2021 | Dec 31, 2021 | -$9.06 | – |
| FY2020 | Dec 31, 2020 | -$37.68 | – |
| FY2019 | Dec 31, 2019 | -$33.00 | – |
| FY2018 | Dec 31, 2018 | -$45.00 | – |
| FY2017 | Dec 31, 2017 | $0.00 | – |
| FY2016 | Dec 31, 2016 | $0.00 | – |
| FY2015 | Dec 31, 2015 | -$90.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | -$0.05 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.04 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.16 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.36 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.37 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.36 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.70 | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.98 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.49 | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.10 | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.65 | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.80 | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.60 | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.29 | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.55 | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.95 | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.95 | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.68 | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.80 | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.00 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.00 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.00 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.00 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.00 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.00 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.00 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.00 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.00 | – |
| Q2 FY2016 | Jun 30, 2016 | $0.00 | – |
| Q1 FY2016 | Mar 31, 2016 | $0.00 | – |
| Q4 FY2015 | Dec 31, 2015 | -$4.16 | – |
| Q3 FY2015 | Sep 30, 2015 | $0.00 | – |
| Q2 FY2015 | Jun 30, 2015 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?